Cencora Inc
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$656.00 | Qghsg | Mkffpjq |
AmerisourceBergen Reports Strong Second-Quarter Results; Raising Our Fair Value Estimate to $155
Overall, we were pleased with AmerisourceBergen's solid performance during the fiscal second quarter, which benefited from a higher-than-expected contribution from COVID-19 treatment distribution. We are raising our fair value estimate to $155 per share from $151 to account for a nominal top- and bottom-line guidance increase by management and a slight uptick in our margin forecast for 2023. We are maintaining our long-term growth and margin expectations, with a slight improvement to operating profit in our 2023 forecast stemming from higher-margin COVID-19 treatment revenue.